JSB Market Research: Chronic Kidney Disease (Chronic Renal Failure)-Pipeline Insights, 2015
Chronic Kidney Disease (Chronic Renal Failure)-Pipeline Insights, 2015, report provides comprehensive insights about pipeline drugs across this Chronic Kidney Disease (Chronic Renal Failure). A key objective of report is to establish the understanding for all the pipeline drugs that fall under Chronic Kidney Disease (Chronic Renal Failure). See Full Report: http://bit.ly/1GfBq3w
Chronic Kidney Disease (Chronic Renal Failure)-Pipeline Insights, 2015, report provides comprehensive insights about pipeline drugs across this Chronic Kidney Disease (Chronic Renal Failure). A key objective of report is to establish the understanding for all the pipeline drugs that fall under Chronic Kidney Disease (Chronic Renal Failure).
See Full Report: http://bit.ly/1GfBq3w
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>)-<strong>Pipeline</strong> <strong>Insights</strong>,<br />
<strong>2015</strong><br />
Released On 10 h April <strong>2015</strong><br />
Synopsis<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>)-<strong>Pipeline</strong> <strong>Insights</strong>, <strong>2015</strong>, report provides<br />
comprehensive insights about pipeline drugs across this <strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong><br />
<strong>Failure</strong>). A key objective of Delve<strong>Insights</strong> report is to establish the understanding for all the<br />
pipeline drugs that fall under <strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>). The report provides<br />
information on the therapeutic development based on the <strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong><br />
<strong>Failure</strong>) providing licensing, chemical, technology information and comparative analysis at various<br />
stages. Delve<strong>Insights</strong> Report is assessing the <strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>)<br />
therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.<br />
In addition to this, thereport has covered the key players and their financial details. Delve<strong>Insights</strong><br />
Reports are also highlighting the discontinued and dormant products for <strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong><br />
(<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>).<br />
<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650 / +91 - 998 729 5242<br />
Published by- http:/www.jsbmarketresearch.com/
Data Sources<br />
The report is built using data and information sourced from proprietary databases, primary and<br />
secondary research and in-house analysis by DelveInsight team of industry experts.<br />
Secondary sources information and data has been collected from various printable and nonprintable<br />
sources like search engines, News websites, Government Websites, Trade Journals, White<br />
papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to<br />
available databases.<br />
Note*: This report requires certain updates. We have all the information available but require 3<br />
business days to complete the process and ensure it is as up-to-date as possible. Certain sections in<br />
the report may be removed or altered based on the availability and relevance of data for the<br />
indicated Indication.<br />
Scope<br />
The report provides a snapshot of the global therapeutic landscape of <strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong><br />
(<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>)<br />
The report provides pipeline products under drug profile section which includes product<br />
description, MOA, licensors & collaborators, development partner and chemical information<br />
Coverage of the <strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) pipeline on the basis of target,<br />
MOA, route of administration, technology involved and molecule type<br />
The report reviews key players involved in the therapeutics development for <strong>Chronic</strong> <strong>Kidney</strong><br />
<strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) and also provide company profiling<br />
The report also gives the information of dormant and discontinued pipeline projects<br />
<strong>Pipeline</strong> products coverage based on various stages of development ranging from preregistration till<br />
discovery and undisclosed stages<br />
Provides pipeline assessment by monotherapy and combination therapy products, stage of<br />
development and molecule type<br />
<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650 / +91 - 998 729 5242<br />
Published by- http:/www.jsbmarketresearch.com/
Reasons to buy<br />
Complete <strong>Pipeline</strong> intelligence and complete understanding over therapeutics development for<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>)<br />
Identify the relationship between the drugs and use it for target finding, drug repurposing, and<br />
precision medicine.<br />
Devise corrective measures for pipeline projects by understanding <strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong><br />
(<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) pipeline depth and focus of Indication therapeutics<br />
Developing strategic initiatives to support your drug development activities.<br />
Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets,<br />
and make the best decisions for your business.<br />
Develop and design in licensing and out licensing strategies by identifying prospective partners<br />
with the most attractive projects to enhance and expand business potential and Scope<br />
Provides strategically significant competitor information, analysis, and insights to formulate<br />
effective R&D development strategies<br />
Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors<br />
that drove them from pipeline<br />
Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions<br />
Browse complete Report on:<br />
http://www.jsbmarketresearch.com/healthcare-medical/r-chronic-kidney-diseasechronic-renal-failure-pipeline-insights-<strong>2015</strong>-170497<br />
<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650 / +91 - 998 729 5242<br />
Published by- http:/www.jsbmarketresearch.com/
Table of Contents<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Overview<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) <strong>Pipeline</strong> Therapeutics<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Therapeutics under Development by Companies<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Late Stage Products (Filed and Phase III)<br />
Comparative Analysis<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Mid Clinical Stage Products (Phase II)<br />
Comparative Analysis<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Early Clinical Stage Products (Phase I and IND<br />
Filed)<br />
Comparative Analysis<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Discovery and Pre-Clinical Stage Products<br />
Comparative Analysis<br />
Drug Candidate Profiles<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Therapeutics Assessment<br />
Assessment by Monotherapy Products<br />
Assessment by Combination Products<br />
Assessment by Route of Administration<br />
Assessment by Molecule Type<br />
<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650 / +91 - 998 729 5242<br />
Published by- http:/www.jsbmarketresearch.com/
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Discontinued Products<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Dormant Products<br />
Companies Involved in Therapeutics Development for <strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong><br />
<strong>Failure</strong>)<br />
Appendix<br />
Methodology<br />
Contact Us<br />
Disclaimer<br />
List Of Tables<br />
Number of Products under Development for <strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>),<br />
<strong>2015</strong><br />
Number of Products under Development by Companies<br />
Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), <strong>2015</strong><br />
Comparative Analysis Mid Clinical Stage Products (Phase II), <strong>2015</strong><br />
Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), <strong>2015</strong><br />
Comparative Analysis Discovery and Pre-Clinical Stage Products, <strong>2015</strong><br />
Drug Candidates Profiles<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Assessment by Monotherapy Products<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Assessment by Combination Products<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Assessment by Route of Administration<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Assessment by Stage and Route of Administration<br />
<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650 / +91 - 998 729 5242<br />
Published by- http:/www.jsbmarketresearch.com/
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Assessment by Molecule Type<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Assessment by Stage and Molecule Type<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Therapeutics Discontinued Products<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Therapeutics Dormant Products<br />
Products under Development by Companies, <strong>2015</strong><br />
List Of Figures<br />
Number of Products under Development for <strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>),<br />
<strong>2015</strong><br />
Late Clinical Stage Products (Filed and Phase III), <strong>2015</strong><br />
Mid Clinical Stage Products (Phase II), <strong>2015</strong><br />
Early Clinical Stage Products (Phase I and IND Filed), <strong>2015</strong><br />
Discovery and Pre-Clinical Stage Products, <strong>2015</strong><br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Assessment by Monotherapy Products<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Assessment by Combination Products<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Assessment by Route of Administration<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Assessment by Stage and Route of Administration<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Assessment by Molecule Type<br />
<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>) Assessment by Stage and Molecule Type<br />
<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650 / +91 - 998 729 5242<br />
Published by- http:/www.jsbmarketresearch.com/
Product Price :<br />
License Type<br />
Price<br />
PDF $ 1250<br />
Site Licence $ 2500<br />
Enterprise Wide Licence $ 4000<br />
Related reports:<br />
Americas Clinical Chemistry Analyzer <strong>Market</strong> by Product (Semi-Automated Clinical<br />
Chemistry and Fully-Automated Clinical Chemistry Analyzer), by End-Users (Academics<br />
<strong>Research</strong> Institutes, Diagnostic Laboratories, Hospitals) - Forecast to 2019<br />
<strong>Chronic</strong> Inflammatory Demyelinating Polyneuropathy (CIDP)-<strong>Pipeline</strong> <strong>Insights</strong>, <strong>2015</strong><br />
Liver Transplantation-<strong>Pipeline</strong> <strong>Insights</strong>, <strong>2015</strong><br />
Local Anesthetic Effect-<strong>Pipeline</strong> <strong>Insights</strong>, <strong>2015</strong><br />
<strong>Chronic</strong> Liver <strong>Disease</strong>-<strong>Pipeline</strong> <strong>Insights</strong>, <strong>2015</strong><br />
Low Back Pain-<strong>Pipeline</strong> <strong>Insights</strong>, <strong>2015</strong><br />
<strong>Chronic</strong> Pancreatitis Pain-<strong>Pipeline</strong> <strong>Insights</strong>, <strong>2015</strong><br />
Lung Adenocarcinoma-<strong>Pipeline</strong> <strong>Insights</strong>, <strong>2015</strong><br />
<strong>Chronic</strong> Plaque Psoriasis-<strong>Pipeline</strong> <strong>Insights</strong>, <strong>2015</strong><br />
<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650 / +91 - 998 729 5242<br />
Published by- http:/www.jsbmarketresearch.com/
Healthcare and Medical <strong>Market</strong> <strong>Research</strong><br />
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details<br />
at contact@jsbmarketresearch.com<br />
About <strong>JSB</strong> <strong>Market</strong> <strong>Research</strong>:-<br />
<strong>JSB</strong> market research is a leading player in the market of research report distribution. It is one-stopshop<br />
for all information related to market research for any sector of the industry. Along with<br />
providing in-depth analysis though reports, <strong>JSB</strong> market research also provides regular updates of<br />
the market though newsletters. Our reports are a well-researched work of market researchers with<br />
an extensive knowledge and a good level of market experience.<br />
To know more on “<strong>Chronic</strong> <strong>Kidney</strong> <strong>Disease</strong> (<strong>Chronic</strong> <strong>Renal</strong> <strong>Failure</strong>)-<strong>Pipeline</strong> <strong>Insights</strong>,<br />
<strong>2015</strong>”<br />
http://www.jsbmarketresearch.com/healthcare-medical/r-chronic-kidney-disease-chronicrenal-failure-pipeline-insights-<strong>2015</strong>-170497<br />
<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650 / +91 - 998 729 5242<br />
Published by- http:/www.jsbmarketresearch.com/
Change language